BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Rothschild in 1990 and is headquartered in Stockholm, Sweden.
Die Corona-Pandemie hat dazu geführt, dass die Gesundheit immer mehr in den Mittelpunkt rückt. Verbraucher sind bewusster geworden und verlangen nach Produkten, die nachweislich sicher, wirksam und von hoher Qualität sind.
